Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol
2002; 39: 1890–1900.
Oyen N, Poulsen G, Boyd HA, et al. Recurrence of congenital heart defects in families. Circulation
2009; 120: 295–301.
Hartman RJ, Rasmussen SA, Botto LD, et al. The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol
2011; 32: 1147–1157.
Rowland TW, Hubbell JP, Nadas AS. Congenital heart disease in infants of diabetic mothers. J Pediatr
1973; 83: 815–820.
Miller A, Riehle-Colarusso T, Siffel C, et al. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet Part A
2011; 155: 2137–2145.
Olshan AF, Schnitzer PG, Baird PA. Paternal age and the risk of congenital heart defects. Teratology
1994; 50: 80–84.
Mills JL, Troendle J, Conley MR, et al. Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr
2010; 91: 1543–1549.
van der Linde D, Konings EM, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol
2011; 58: 2241–2247.
Restivo A, Piacentini G, Placidi S, et al. Cardiac outflow tract: a review of some embryogenetic aspects of the conotruncal region of the heart. Anat Rec A Discov Mol Cell Evol Biol
2006; 288: 936–943.
Adams MM, Mulinare J, Dooley K. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol
1989; 14: 432–442.
Johnson MC, Hing A, Wood MK, et al. Chromosomal anomalies in congenital heart disease. Am J Med Genet
1997; 70: 292–298.
O’Malley CD, Shaw GM, Wasserman CR, et al. Epidemiologic characteristics of conotruncal heart defects in California, 1987–1988. Teratology
1996; 53: 374–377.
Francannet C, Lancaster PA, Pradat P, et al. The epidemiology of three serious cardiac defects. A joint study between five centres. Eur J Epidemiol
1993; 9: 607–616.
Lary JM, Paulozzi LJ. Sex differences in the prevalence of human birth defects: a population-based study. Teratology
2001; 64: 237–251.
Grech V. Diagnostic and interventional trends in tetralogy of Fallot and trans-position of the great arteries in a population-based study. Pediatr Cardiol
2000; 21: 368–373.
Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology
2001; 64: 98–106.
Ferencz C, Rubin JD, McCarter RJ, et al. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology
1990; 141: 319–326.
Sayasathid J, Sukonpan K, Somboonna N. Epidemiology and etiology of congenital heart diseases. In: Syamasundar Rao P, ed. Congenital Heart Disease – Selected Aspects. InTech, Rijeka, Croatia, 2012: 47–84.
Dolk H, Loane M, EUROCAT Steering Committee. Congenital heart defects in Europe prevalence and perinatal mortality, 2000 to 2005. Circulation 2011: 841–849.
Wu MH, Chen HC, Lu CW, et al. Prevalence of congenital heart disease at live birth in Taiwan. J Pediatr
2010; 156: 782–785.
Reller MD, Stricklland MJ, Richle-Colarusso T, et al. Prevalence of congenital heart defect in metropolitan Atlanta, 1998–2005. J Pediatr
2008; 153: 803–813.
Jaber L, Merlob P, Shohat M. High incidence of central nervous system malformations associated with marked parental consanguinity in an Israeli Arab community. Biomed Pharmacother
1994; 48: 351–354.
Dolk H, Loane M, Game E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol
2010; 686: 349–364.
Bjornard K, Riehle-Colarusso T, Gilboa SM, et al. Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol
2013; 97: 87–94.
Øyen N, Poulsen G, Boyd HA, et al. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J
2009; 157: 467–473.e1.
Leirgul E, Fomina T, Brodwall K, et al. Birth prevalence of congenital heart defects in Norway 1994-2009 – a nationwide study. Am Heart J
2014; 168: 956–964.
Jaber L, Halpern GJ, Shohat M. The impact of consanguinity worldwide. Community Genet
1998; 1: 12–17.
Kulkarni ML, Kurian M. Consanguinity and its effect on fetal growth and development: a south Indian study. J Med Genet
1990; 27: 348–352.
Jaber L, Merlob P, Bu X, Rotter JI, Shohat M. Marked parental consanguinity as a cause for increased major malformations in an Israeli Arab community. Am J Med Genet
1992; 44: 1–6.
Grjibovski AM, Magnus P, Stoltenberg C. Decrease in consanguinity among parents of children born in Norway to women of Pakistani origin: a registry-based study. Scand J Public Health
2009; 37: 232–238.
El-Shafei A, Rao PSS, Sandhu AK. Congenital malformations and consanguinity. Aust NZ J Obstet Gynaecol
1986; 26: 168–172.
Magnus P, Berg K, Bjerkedal T. Association of parental consanguinity with decreased birth weight and increased rate of early death and congenital malformations. Clin Genet
1985; 28: 335–342.
Fung A, Manlhiot C, Naik S, et al. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc
2013; 2: e000064.
Zhang L, Zhang XH, Ren MH, et al. Chromosome abnormalities and congenital heart diseases: a retrospective on 49 cases. Sichuan Da Xue Xue Bao Yi Xue Ban
2010; 41: 312–315.
Harris JA, Francannet C, Pradat P, et al. The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations. Pediatr Cardiol
2003; 24: 222–235.
Garne E, Nielsen G, Hansen OK, et al. Tetralogy of Fallot. A population-based study of epidemiology, associated malformations and survival in western Denmark 1984-1992. Scand Cardiovasc J
1999; 33: 45–48.
Beauchesne LM, Warnes CA, Connolly HM, et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol
2005; 45: 595–598.
Boudjemline Y, Fermont L, Le Bidois J, et al. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr
2001; 138: 520–524.
Cuneo BF. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr
2001; 13: 465–472.
Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med
2001; 3: 14–18.
Nora JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol
1994; 23: 1468–1471.
Csáky-Szunyogh M, Vereczkey A, Kósa Z, et al. Risk and protective factors in the origin of conotruncal defects of heart – a population-based case–control study. Am J Med Genet A
2013; 161A: 2444–2452.